SciSparc (SPRC) Shares Outstanding (2017 - 2025)
SciSparc (SPRC) posted Shares Outstanding (Entity) of $81.0 for Q4 2025, up 305.0% sequentially from $20.0 in Q4 2024, and up 305.0% YoY from $20.0 in Q4 2024.
SciSparc (SPRC) Shares Outstanding (2017 - 2025) Analysis & Trends
SciSparc has reported Shares Outstanding (Entity) for 3 years, with the latest figure at $81.0 in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 305.0% year-over-year to $81.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $81.0 (up 305.0% YoY) and the FY2025 annual result came in at $81.0, up 305.0% from the prior year.
- Shares Outstanding (Entity) improved to $81.0 in Q4 2025 per SPRC's latest filing, from $20.0 in the prior quarter.
- Over five years, Shares Outstanding (Entity) peaked at $81.0 in Q4 2025 and troughed at $1.0 in Q4 2023.
- A 3-year average of $34.0 and a median of $20.0 in 2024 frame the typical range for Shares Outstanding (Entity).
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Entity) soared 1900.0% in 2024, then soared 305.0% in 2025.
- Over 3 years, Shares Outstanding (Entity) stood at $1.0 in 2023, then jumped by 1900.0% to $20.0 in 2024, then jumped by 305.0% to $81.0 in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $81.0, $20.0, and $1.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | SciSparc | 831,418.60 | 831,418.60 | - | 124,185.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 124,185.00 |
| Jun 30, 2025 | 30,821.00 |
| Dec 31, 2024 | 30,821.00 |
| Jun 30, 2024 | 2,159.00 |
| Dec 31, 2023 | 2,159.00 |
| Jun 30, 2023 | 1.00 |
| Dec 31, 2022 | 1.00 |
| Jun 30, 2020 | 1.00 |
| Dec 31, 2019 | 1.00 |
| Jun 30, 2019 | 1.00 |
| Mar 31, 2019 | 1.00 |
| Dec 31, 2018 | 1.00 |
| Sep 30, 2018 | 1.00 |
| Jun 30, 2018 | 1.00 |
| Mar 31, 2018 | 1.00 |
| Dec 31, 2017 | 1.00 |